Dec 5, 2019
Vernakalent, CV death in cancer patients, dapagliflozin, and
sacubitril/valsartan are the topics Dr. John Mandrola discusses in
this week’s podcast.
Recent Facebook Posts
This podcast delivers Dr. John Mandrola’s summary and perspective on top news of the week that cardiologists can’t miss. This podcast is intended for US health professionals only.
Having trouble logging in?